31
Oct
2006
GlobeImmune has announced positive interim data from their randomized, double-blinded placebo-controlled Phase Ib study of their GI-5005 Tarmogen in patients with hepatitis C virus (HCV). To date GI-5005 is well tolerated with no serious adverse events reported. The preliminary data has demonstrated that the treatment has converted subjects with a weak cellular immune response, typical [...]
30
Oct
2006
And the Colorado M&A hits keep on coming…Merck & CO. (NYSE: MRK) announced the $1.1 billon acquisition of San Francisco headquartered Sirna Therapeutics, Inc. (NASDQ: RNAI). Why does an acquisition story about an acquirer from New Jersey and an acquiree from San Francisco make it onto the virtual pages of Colorado Life Science Deal Flow [...]
23
Oct
2006
Following Replidyne’s (NASDAQ: RDYN) receipt of a non-approvable letter from the FDA for Faropenem® there are numerous reasons why there is a sliver lining in this non-approvable letter cloud. First, and of paramount importance, the FDA had no SAFETY or Chemistry Manufacturing and Control issues. Second, the IP which covers composition of matter and methods [...]
22
Oct
2006
Sunday Non Sequitur
Posted in My Rants
I have been spending a little time this Sunday evening working to spruce up the sidebar, mission statement, and permanently embed the Colorado Bioscience movie; for I feel this ten minute film is a wonderful resource and should be easily accessible. There are some regular readers of this blog, to those of you I am [...]
18
Oct
2006
Efficas: $14.5M Series B
Posted in Series B
Efficas, Inc., a biotech health, wellness and medical foods company focused on nutritional management of the immune system, has raised $14.5M in Series B funding. LSP BioVentures led the deal, and was joined by Unilever Technology Ventures and included return backers Burrill & Co., Great Spirit Ventures, JPMorgan Bay Area Equity Fund and Prolog Ventures. [...]
17
Oct
2006
Colorado Life Science Movie
Posted in My Rants
CLICK ON THE ARROW TO PLAY Thank you to the following entities for aiding in the creation of this ten-minute encapsulation of the state of bioscience in Colorado: Colorado Bioscience AssociationColorado Office of Economic Development and International TradeForest City EnterprisesFitzsimons Redevelopment AuthorityAurora Economic Development CouncilAmgenRoche If there are any blogger-experts out there who know how [...]
16
Oct
2006
Can’t Get Enough Stem Cells?
Posted in My Rants
…Then don’t miss out on the 23rd University Colorado, Boulder MCDB Graduate Student Symposium on Stem Cell Biology. Congresswoman Diana DeGette and James Battey, M.D., Ph.D. (Chair, NIH Stem Cell Task Force) are the keynote session speakers. Festivities kick off Friday 20 October. For more information and registration check (here).
13
Oct
2006
Congratulations to Harry Ross and the entire RxKinetix team on the Endo Pharmaceuticals Holdings, Inc. (NASDAQ: ENDP) deal. The disclosed terms indicate Endo Pharma will pay a $20M up-front fee and will follow on with up to an additional $95M in clinical development and regulatory milestone payments. Early indications are that RxKinteix, like Myogen, will [...]
09
Oct
2006
MIT Enterprise Forum in Colorado
Posted in Events
Have you ever wondered about Stem Cells? Then Don’t miss this event…Thursday 12 October 5:00-7:00pm at the Colorado Bioscience Park Aurora @ Fitzsimons. The Promise of Stem Cells: Separating Hype from Reality The MIT Enterprise Forum and the MIT Club of Colorado presents a scientific look at embyonic stem cell research and examine its influence [...]
03
Oct
2006
What an Honor It is…
Posted in My Rants
…To be pinged by the papers for my thoughts and ruminations on the Myogen (NASDAQ: MYOG) and Gilead (NASDAQ: GILD) deal. Christine Tatum and Alicia Wallace are skilled in their trade and I humbled and appreciative to be called upon. RE: the Daily Camera article Please let it be known that I am the Assistant [...]
Life Science Deal Flow PARTNERS
-
